WLBHF is a non-profit organization whose major goal is to foster discoveries in pediatric acute lymphocytic leukemia with a goal of developing effective therapies for the disease. Applicants must be either an established investigator with an association to an academic institution or must be part of a lab working with an established investigator.
Grant applications should be no greater than 7 pages (Abstract, Background, Experimental Design, Expected Results, Potential Problems. Please use: 10 point font, Arial, single spaced). Also include: Reference, detailed Timeline, Budget Justification, Other Support and Biosketch (NIH format). Last year, 13 grants were awarded; emphasis was placed on the translational merits of the proposal.
Priority will be given to those grants that have a translational bent getting new therapies to children with leukemias. Further areas of studies would be to identify new targets that could be used for therapy.
Funding: Grants are limited to 0,000/year (direct costs). Grants are reviewed on a yearly basis and those that are funded and meet their milestones may be renewed ona yearly basis for up to 2 subsequent years. Indirect costs are limited to 10% per year. Initial grant will be funded for one year.
Review of grant: All applicants are reviewed by the grant committee and final approval rests with the Board of Directors. Awarding of the grant is based on the priority score and the availability of funds.
Send grants electronically to: Koeffler@cshs.org. H. Phillip Koeffler, M.D., Director of Hematology/Oncology Division, Cedars-Sinai Medical Center, 8700 Beverly Blvd., PACT500A, Los Angeles, CA 90048.
Grant deadline: October 18, 2011. No late applications. Notification of funding decision should occur by about December 21, 2011. Funding period: January 1, 2012 - December 31, 2012.
Please click HERE to download the application form.